|
PAQR3 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.458190E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.660200E-01 |
| Normal-vs-AfricanAmerican |
4.033900E-02 |
| Normal-vs-Asian |
3.315400E-01 |
| Caucasian-vs-AfricanAmerican |
4.887600E-01 |
| Caucasian-vs-Asian |
2.405800E-01 |
| AfricanAmerican-vs-Asian |
6.034100E-02 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.153800E-01 |
| Normal-vs-Female |
7.314000E-02 |
| Male-vs-Female |
4.423200E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.005500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.352800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.425500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.894100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.274400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.778600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.299800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.745200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.798000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.218600E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
9.033900E-02 |
| Normal-vs-Pheochromocytoma |
1.605190E-01 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
9.063800E-02 |
| Paraganglioma-vs-Pheochromocytoma |
7.420600E-01 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
9.569600E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
7.406800E-01 |
|
|
